ELISABETH OWEN: Open Payments
NPI 1417589474 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$949 in 43 payments from 12 companies in 2025. Trend: 2023 $1,320 · 2024 $1,998 · 2025 $949
Food & beverage: $949
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $222 |
| Calliditas Therapeutics US Inc. | 8 | $178 |
| AstraZeneca Pharmaceuticals LP | 9 | $155 |
| Otsuka America Pharmaceutical, Inc. | 6 | $144 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $69 |
| Lilly USA, LLC | 2 | $40 |
| Alexion Pharmaceuticals, Inc. | 1 | $34 |
| Fresenius USA Marketing, Inc. | 1 | $23 |
| OPKO Pharmaceuticals, LLC | 1 | $23 |
| Mallinckrodt Hospital Products Inc. | 1 | $22 |
Products named: Fabhalta, TARPEYO, FARXIGA, JYNARQUE, JARDIANCE, ULTOMIRIS, VELPHORO, RAYALDEE.
Industry payments across AL — which companies pay providers there.
